enter here
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)
About the study
NCT Trial Number
NCT04077437
The drug being studied
MDMA
Sponsored by
Multidisciplinary Association for Psychedelic Studies
Trial Start Date
Jul-20
About the participants
Age seeking
18 Years and older
gender
All
Primary condition of volunteers accepted
PTSD (Post Traumatic Stress Disorder)
Accepts healthy volunteers?
No
This study assesses the efficacy and safety of MDMA-assisted psychotherapy compared to psychotherapy in patients with severe PTSD.
Locations
United States, California
New School Research LLT
North Hollywood, California, United States, 91601
Contact: Study Coordinator
818-643-5234
info@newschoolresearch.com
San Francisco Insight and Integration Center
San Francisco, California, United States, 94114
Contact: Study Coordinator
415-400-5722
info@sfinsightcenter.com
University of California San Francisco
San Francisco, California, United States, 94122
Contact: Study Coordinator
510-985-3522
mdma.research@ucsf.edu
United States, Colorado
Aguazul-Blue Water Inc.
Boulder, Colorado, United States, 80302
Contact: Study Coordinator
720-892-8395
info.boulderstudy@comcast.net
Wholeness Center
Fort Collins, Colorado, United States, 80525
Contact: Study Coordinator
970-825-6610
wcresearch@wholeness.com
United States, Louisiana
Ray Worthy Psychiatry LLC
New Orleans, Louisiana, United States, 70123
Contact: Study Coordinator
504-323-5584
info@nolamdmaresearch.com
United States, Massachusetts
Trauma Research Foundation
Boston, Massachusetts, United States, 02446
Contact: Study Coordinator
617-651-2646
mdma.study.boston@gmail.com
United States, New York
New York University
New York, New York, United States, 10016
Contact: Study Coordinator
646-501-4206
MDMA.Research@nyumc.org
New York Private Practice
New York, New York, United States, 10024
Contact: Study Coordinator
917-830-4948
info@mdma.nyc